In a 75‑kg patient taking prednisone 30 mg, what rapid‑acting insulin dose (units) and NPH insulin dose should be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dosing for Glucocorticoid-Induced Hyperglycemia

For this 75-kg patient on prednisone 30 mg, administer 7.5 units of NPH insulin in the morning with the prednisone dose, plus continue rapid-acting insulin at 0.1 units/kg (7.5 units) distributed as prandial and correction doses throughout the day.

Rationale and Dosing Algorithm

The guideline-based approach for prednisone-induced hyperglycemia specifically recommends NPH insulin matched to the glucocorticoid timing and dose 1. Since your patient needed only 8 units of short-acting insulin yesterday, this indicates relatively modest insulin requirements.

NPH Insulin Calculation

For prednisone 30 mg, the recommended NPH dosing is 0.1-0.4 units/kg per 10 mg prednisone increment 1. Given your patient's low previous insulin requirement (8 units total), start conservatively:

  • NPH dose: 0.1 units/kg = 0.1 × 75 kg = 7.5 units
  • Administer this in the morning simultaneously with the prednisone dose 1
  • This matches the prednisone-induced afternoon/evening hyperglycemia pattern

Rapid-Acting Insulin Distribution

Your planned 0.1 units/kg (7.5 units) of rapid-acting insulin should be distributed as:

  • Prandial doses: Split across meals, with larger portions at lunch and dinner (when prednisone effect peaks) 1
  • Correction doses: Use sliding scale with insulin sensitivity factor 1:25, targeting glucose <150 mg/dL 1

Key Clinical Considerations

Timing is critical: NPH must be given with the morning prednisone dose because prednisone causes hyperglycemia predominantly from midday through midnight 2. The intermediate-acting profile of NPH (peak 4-12 hours) matches this pattern better than long-acting basal insulins 1, 3.

Why this conservative approach: Your patient's previous requirement of only 8 units suggests insulin sensitivity. Research shows that for prednisone 30 mg (medium-dose range), the optimal total insulin-to-steroid ratio is approximately 0.257 U/kg/10-mg prednisone equivalent 4. For 30 mg prednisone in a 75-kg patient, this calculates to approximately 58 units total daily—but this is for patients with established diabetes. Your patient's low previous requirement justifies starting at the lower end of the guideline range (0.1 units/kg for NPH) 1.

Titration Strategy

Increase NPH by 10% daily until fasting and afternoon glucose targets are achieved 1. If hyperglycemia persists after 24-48 hours, escalate NPH to 0.2-0.3 units/kg (15-22.5 units) 1. Research supports that more aggressive NPH dosing (0.5 units/mg prednisone equivalent, which would be 15 units for 30 mg prednisone) achieves euglycemia faster without increasing hypoglycemia 3.

Common Pitfalls to Avoid

  • Don't use glargine or detemir as primary therapy: These long-acting insulins don't match prednisone's temporal effect and may cause nocturnal hypoglycemia while undertreating daytime hyperglycemia 2
  • Don't delay NPH initiation: Start NPH on day 1 if the patient has known diabetes; if no prior diabetes diagnosis, start on day 2 1
  • Don't forget to adjust when prednisone dose changes: NPH should be reduced proportionally when prednisone is tapered 1

The evidence strongly supports NPH as the preferred intermediate-acting insulin for prednisolone/prednisone-induced hyperglycemia over basal insulin analogs 1, 3, 2, 5.

References

Guideline

glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in covid-19 infection: a systematic review.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Research

Insulin Dosing and Glycemic Outcomes Among Steroid-treated Hospitalized Patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2022

Related Questions

For a patient taking prednisone 60 mg daily, NPH insulin 4 units, insulin‑to‑carbohydrate ratio 1 unit per 7 g carbohydrate, and insulin sensitivity factor 1 unit per 40 mg/dL (blood glucose 151, 124, 141 mg/dL), if the prednisone dose is reduced to 50 mg, what should the NPH dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
If a diabetic patient is started on prednisone, should the basal (long‑acting) insulin dose be increased?
In a 67‑year‑old, 73‑kg liver‑transplant patient receiving 500 mg methylprednisolone at 8 am with persistent hyperglycemia, should the 8 am NPH insulin dose be given as a pure basal dose without a correction factor?
For a 47-year-old male weighing 120 kg who is on dexamethasone 10 mg every 6 hours, what should the 10 am NPH (neutral protamine Hagedorn) insulin dose be, what should the 8 pm NPH dose be, and what should the insulin sensitivity factor (ISF) and insulin-to-carbohydrate ratio (ICR) be after changing dexamethasone to 10 mg every 8 hours?
What should the insulin-to-carbohydrate ratio for the 8 am NPH insulin dose be in a 62‑year‑old female with type 2 diabetes, weight 43.8 kg, on prednisone 20 mg daily, using 22 units NPH insulin and current ICR 15 for breakfast and lunch, given her recent blood glucose readings?
How should skin involvement be evaluated and treated in a patient with systemic vasculitis?
Is bowel rest indicated for patients with gastritis?
Can a pregnant woman safely use Cepacol (benzydamine) lozenges for sore throat?
What considerations should be taken into account when performing a bone biopsy in a patient on Fosamax (alendronate)?
How should bowel rest be managed in a patient with intractable vomiting due to gastritis?
Is a perforation of the right tympanic membrane concerning?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.